|
PCSA | Processa Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.08 |
| Leverage | 23.09% |
| Market Cap | $ 77.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -12.9m |
| Margin | -8441.82% |
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients with unmet medical needs in the United States. The company is headquartered in Hanover, Maryland.